奧士康(002913.SZ):擬向銀行等金融機構申請綜合授信額度累計不超60億元
格隆匯 12 月 17日丨奧士康(002913.SZ)公佈,為滿足公司及全資、控股子公司經營發展的需要,公司及全資、控股子公司擬向銀行等金融機構申請綜合授信額度累計不超過人民幣60億元,單個銀行授信額度不超過人民幣20億元。若涉及擔保事項,公司將另行審議。
以上申請的授信額度、授信期限最終以銀行實際審批的授信額度、授信期限為準,銀行授信用途包括但不限於流動資金貸款、銀行承兑匯票額度、信用證額度等,具體融資金額將視公司運營資金的實際需求來確定,以銀行與公司實際發生的融資金額為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.